Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Statements.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society Committee for Epidemiology and Clinical Management of Atherosclerosis. Teramoto T, et al. Among authors: hiro t. J Atheroscler Thromb. 2014;21(4):299-303. doi: 10.5551/jat.ed002. Epub 2014 Apr 12. J Atheroscler Thromb. 2014. PMID: 24727684 Free article. No abstract available.
More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
Arai H, Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M; JAPAN-ACS Investigators. Arai H, et al. Among authors: hiro t. J Atheroscler Thromb. 2010 Oct 27;17(10):1096-107. doi: 10.5551/jat.5660. Epub 2010 Jul 28. J Atheroscler Thromb. 2010. PMID: 20675955 Free article. Clinical Trial.
Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
Ohashi T, Shibata R, Morimoto T, Kanashiro M, Ishii H, Ichimiya S, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura T, Daida H, Murohara T, Matsuzaki M. Ohashi T, et al. Among authors: hiro t. Atherosclerosis. 2010 Sep;212(1):237-42. doi: 10.1016/j.atherosclerosis.2010.05.005. Epub 2010 May 11. Atherosclerosis. 2010. PMID: 20684825 Clinical Trial.
Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K, Kimura T, Kimura K, Morimoto T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Saito S, Yamaguchi T, Daida H, Matsuzaki M; JAPAN-ACS Investigators. Hibi K, et al. Among authors: hiro t. Atherosclerosis. 2011 Dec;219(2):743-9. doi: 10.1016/j.atherosclerosis.2011.08.024. Epub 2011 Aug 22. Atherosclerosis. 2011. PMID: 21899843 Clinical Trial.
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society. Teramoto T, et al. Among authors: hiro t. J Atheroscler Thromb. 2013;20(6):517-23. doi: 10.5551/jat.15792. Epub 2013 May 11. J Atheroscler Thromb. 2013. PMID: 23665881 Free article. No abstract available.
Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society (JAS). Teramoto T, et al. Among authors: hiro t. J Atheroscler Thromb. 2013;20(7):603-15. doi: 10.5551/jat.15867. Epub 2013 Jul 25. J Atheroscler Thromb. 2013. PMID: 23883545 Free article. No abstract available.
Diagnostic criteria for dyslipidemia.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: hiro t. J Atheroscler Thromb. 2013;20(8):655-60. doi: 10.5551/jat.17152. Epub 2013 Jul 26. J Atheroscler Thromb. 2013. PMID: 23892528 Free article. No abstract available.
Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: hiro t. J Atheroscler Thromb. 2013;20(10):733-42. doi: 10.5551/jat.17368. Epub 2013 Jul 26. J Atheroscler Thromb. 2013. PMID: 23892529 Free article. No abstract available.
Absolute risk of cardiovascular disease and lipid management targets.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Teramoto T, et al. Among authors: hiro t. J Atheroscler Thromb. 2013;20(9):689-97. doi: 10.5551/jat.17392. Epub 2013 Jul 26. J Atheroscler Thromb. 2013. PMID: 23892530 Free article. No abstract available.
151 results